PPIG and infection: The administration of immunosuppressants (ATC-L04) can result in DDIs either due to synergisms and the risk of serious infection (i.e., abatacept and adalimumab) or impact the CYP abundance and change drugs’ intrinsic clearance (PK-DDIs) through the liver (i.e., anakinra and alprazolam).